Announcements Trials

Browse Landscape

Status

Withdrawn 1 Unknown 1

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Breast Neoplasms 438 Neoplasms 322 Carcinoma, Non-Small-Cell Lung 250 Prostatic Neoplasms 240 Lung Neoplasms 176 Colorectal Neoplasms 158 Pancreatic Neoplasms 148 Neoplasm Metastasis 142 Leukemia, Myeloid, Acute 140 Multiple Myeloma 131 Lymphoma 128 Carcinoma, Hepatocellular 127 Ovarian Neoplasms 109 Melanoma 109 Head and Neck Neoplasms 101 Brain Neoplasms 101 Recurrence 100 Leukemia 97 Leukemia, Lymphocytic, Chronic, B-Cell 96 Precursor Cell Lymphoblastic Leukemia-Lymphoma 90 Glioblastoma 85 Lymphoma, Non-Hodgkin 83 Colonic Neoplasms 79 Squamous Cell Carcinoma of Head and Neck 76 Lymphoma, Follicular 76 Carcinoma, Renal Cell 75 Lymphoma, Large B-Cell, Diffuse 71 Hematologic Neoplasms 69 Sarcoma 60 Stomach Neoplasms 58

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × Upper Tract Urinary Carcinoma × Clear all

NCT05349812 2024-04-09

DEDUCT

Pacific Edge Limited

Upper Tract Urinary Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡